Ciliary Body and Choroid Melanoma, Small Size Completed Phase 2 Trials for Dacarbazine (DB00851)

IndicationStatusPhase
DBCOND0030836 (Ciliary Body and Choroid Melanoma, Small Size)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01100528Dacarbazine and Recombinant Interferon Alfa-2b in Treating Patients With Primary Uveal Melanoma With Genetic ImbalanceTreatment